参考文献/References:
[1]佚名.超过14亿的全球高血压患者收缩压目标[J].中华老年心脑血管病杂志,2019,21(12):1313.[2] Simonetti F,Piccolo R,Esposito G. Renal denervation and long-term results[J]. Eur Heart J Suppl,2023,25(suppl B):B85-B89.?/div>
[3] Nakagami H. Challenges in the development of novel therapies,vaccines and siRNAs for the treatment of hypertension[J]. Hypertens Res,2023,46(7):1812-1815.?/div>
[4] Fadl Elmula FEM,Mariampillai JE,Heimark S,et al. Medical measures in hypertensives considered resistant[J]. Am J Hypertens,2024,37(5):307-317.
[5] Katsurada K,Kario K. Emerging topics on renal denervation in hypertension:anatomical and functional aspects of renal nerves[J]. Hypertens Res,2023,46(6):1462-1470.?/div>
[6] Triposkiadis F,Briasoulis A,Sarafidis P,et al. The sympathetic nervous system in hypertensive heart failure with preserved LVEF[J]. J Clin Med,2023,12(20):6486.?/div>
[7] Gauthier MM,Hayoz S,Banek CT. Neuroimmune interplay in kidney health and disease:role of renal nerves[J]. Auton Neurosci,2023,250:103133.?/div>
[8] Moiseeva A,Caraus A,Ciobanu A,et al. The impact of renal denervation treatment on left ventricular remodeling in patients with resistant hypertension[J]. Eur J Prev Cardiol,2021. DOI:10.1093/eurjpc/zwab061.159.
[9] Shah RT,Wang BX. Effectiveness of renal denervation in the treatment of hypertension:a literature review[J].?lin Hypertens,2022,28(1):11.
[10] Kiuchi MG,Esler MD,Fink GD,et al. Renal denervation update from the international sympathetic nervous system summit:JACC state-of-the-art review[J]. J Am Coll Cardiol,2019,73(23):3006-3017.?/div>
[11] Kandzari DE,Townsend RR,Kario K,et al. Safety and efficacy of renal denervation in patients taking antihypertensive medications[J]. J Am Coll Cardiol,2023,82(19):1809-1823.?/div>
[12] Bohm M,Kario K,Kandzari DE,et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications(SPYRAL HTN-OFF MED Pivotal):a multicentre,randomised,sham-controlled trial[J]. Lancet,2020,395(10234):1444-1451.
[13] Reyes KRL,Rader F. Long-term safety and antihypertensive effects of renal denervation:current insights[J]. Integr Blood Press Control,2023,16:59-70.
[14] Azizi M,Sanghvi K,Saxena M,et al. Ultrasound renal denervation for hypertension resistant to a triple medication pill(RADIANCE-HTN TRIO):a randomised,multicentre,single-blind,sham-controlled trial[J].?ancet,2021,397(10293):2476-2486.?/div>
[15]Gao F. Efficacy and safety of the Netrod radiofrequency renal denervation system[C]. Paris:EuroPCR,2023.
[16] 李悦,卢成志.经皮去肾神经术:最新证据与患者筛选[J].心血管病学进展,2024,45(3):211-215.
[17] 阳康,江洪. 颈动脉窦压力感受性反射激活在心血管疾病中的应用[J].海南医学,2015,26(10):3.
[18] Illig KA,Levy M,Sanchez L,et al. An implantable carotid sinus stimulator for drug-resistant hypertension:surgical technique and short-term outcome from the multicenter phaseⅡ Rheos feasibility trial[J].? Vasc Surg,2006,44(6):1213-1218.
[19] Groenland EH,Spiering W. Baroreflex amplification and carotid body modulation for the treatment of resistant hypertension[J]. Curr Hypertens Rep,2020,22(4):27.
[20] Wallbach M,Born E,K?pfer D,et al. Long-term effects of baroreflex activation therapy:2-year follow-up data of the BAT Neo system[J]. Clin Res Cardiol,2020,109(4):513-522.
[21] Bates MC,Stone GW,Chen CY,et al. Device profile of the MobiusHD EVBA system for the treatment of resistant hypertension:overview of its mechanism of action,safety and efficacy[J]. Expert Rev Med Devices,2020,17(7):649-658.
[22] Capilupi MJ,Kerath SM,Becker LB. Vagus nerve stimulation and the cardiovascular system[J]. Cold Spring Harb Perspect Med,2020,10(2):a034173.?/div>
[23] Nearing BD,Libbus I,Amurthur B,et al. Acute autonomic engagement assessed by heart rate dynamics during vagus nerve stimulation in patients with heart failure in the ANTHEM-HF trial[J].? Cardiovasc Electrophysiol,2016,27(9):1072-1077.
[24] Plachta DT,Gierthmuehlen M,Cota O,et al. Blood pressure control with selective vagal nerve stimulation and minimal side effects[J]. J Neural Eng,2014,11(3):036011.?/div>
[25] Garcia RG,Staley R,Aroner S,et al. Optimization of respiratory-gated auricular vagus afferent nerve stimulation for the modulation of blood pressure in hypertension[J]. Front Neurosci,2022,16:1038339.?/div>
[26] Jiang Y,Po SS,Amil F,et al. Non-invasive low-level tragus stimulation in cardiovascular diseases[J]. Arrhythm Electrophysiol Rev,2020,9(1):40-46.?/div>
[27] Wang L,Wang Y,Wang Y,et al. Transcutaneous auricular vagus nerve stimulators:a review of past,present,and future devices[J]. Expert Rev Med Devices,2022,19(1):43-61.
[28] Neuhuber WL,Berthoud HR. Functional anatomy of the vagus system-emphasis on the somato-visceral interface[J].?uton Neurosci,2021,236:102887.?/div>
[29] Wehrwein EA,Joyner MJ. Regulation of blood pressure by the arterial baroreflex and autonomic nervous system[J]. Handb Clin Neurol,2013,117:89-102.?/div>
[30] Carandina A,Rodrigues GD,di Francesco P,et al. Effects of transcutaneous auricular vagus nerve stimulation on cardiovascular autonomic control in health and disease[J]. Auton Neurosci,2021,236:102893.
[31] de Moraes TL,Costa FO,Cabral DG,et al. Brief periods of transcutaneous auricular vagus nerve stimulation improve autonomic balance and alter circulating monocytes and endothelial cells in patients with metabolic syndrome:a pilot study[J]. Bioelectron Med,2023,9(1):7.
[32] Kaniusas E,Kampusch S,Tittgemeyer M,et al. Current directions in the auricular vagus nerve stimulation I-A physiological perspective[J]. Front Neurosci,2019,13:854.
[33] Mahfoud F,Schlaich MP,Lobo MD. Device therapy of hypertension[J]. Circ Res,2021,128(7):1080-1099.?/div>
[34] Chomanskis Z,Jonkus V,Danielius T,et al. Hypotensive effect of electric stimulation of caudal ventrolateral medulla in freely moving rats[J]. Medicina(Kaunas),2023,59(6):1046.
[35] Hyam JA,Kringelbach ML,Silburn PA,et al. The autonomic effects of deep brain stimulation—A therapeutic opportunity[J]. Nat Rev Neurol,2012,8(7):391-400.?/div>
[36] Green AL,Wang S,Bittar RG,et al. Deep brain stimulation:a new treatment for hypertension?[J]. J Clin Neurosci,2007,14(6):592-595.?/div>
[37] O’Callaghan EL,Hart EC,Sims-Williams H,et al. Chronic deep brain stimulation decreases blood pressure and sympathetic nerve activity in a drug- and device-resistant hypertensive patient[J]. Hypertension,2017,69(4):522-528.
[38] O’Callaghan EL,McBryde FD,Patel NK,et al. Examination of the periaqueductal gray as a site for controlling arterial pressure in the conscious spontaneously hypertensive rat[J]. Auton Neurosci,2022,240:102984.
[39] Lacuey N,Hampson JP,Theeranaew W,et al. Cortical structures associated with human blood pressure control[J]. JAMA Neurol,2017,75(2):194-202.?/div>
[40] Guo ZL,Tjen-A-Looi SC,Nguyen AT,et al. Adenosine A2A receptors in the rostral ventrolateral medulla participate in blood pressure decrease with electroacupuncture in hypertensive rats[J]. Front Cardiovasc Med,2023,10:1275952.
相似文献/References:
[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(9):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(9):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(9):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(9):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(9):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[6]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(9):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[7]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(9):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[8]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[9]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[10]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]